Other
Coronary intervention
Coronary intervention is an intervention with 6 clinical trials. Historical success rate of 80.0%.
Total Trials
6
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
80.0%
Based on 4 completed trials
Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
50%(2 trials)
Terminated
1(17%)
Phase Distribution
Ph not_applicable
2
33%
Ph phase_4
1
17%
Ph phase_3
1
17%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution4 total trials
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
80.0%
4 of 5 finished
Non-Completion Rate
20.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(4)
Terminated(1)
Other(1)
Detailed Status
Completed4
Terminated1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
80.0%
Most Advanced
Phase 4
Trials by Phase
Phase 31 (25.0%)
Phase 41 (25.0%)
N/A2 (50.0%)
Trials by Status
completed467%
terminated117%
unknown117%
Recent Activity
0 active trials
Showing 5 of 6
terminated
Time for a Paradigm Shift: STEMI/NSTEMI to OMI/NOMI ?
NCT05705102
completedphase_4
Preventive PCI or Medical Therapy Alone for Vulnerable Atherosclerotic Coronary Plaque
NCT02316886
completednot_applicable
DESolve Post-Approval Study
NCT02013349
unknown
The Angiography Characteristic of Free Wall Ruptrue in STEMI
NCT04213599
completednot_applicable
Evaluation of HealinG of Polymer-Free Biomlimus A9-Coated Stent by Optical Coherence Tomography (EGO-BIOFREEDOM)
NCT01760876
Clinical Trials (6)
Showing 6 of 6 trials
NCT05705102
Time for a Paradigm Shift: STEMI/NSTEMI to OMI/NOMI ?
NCT02316886Phase 4
Preventive PCI or Medical Therapy Alone for Vulnerable Atherosclerotic Coronary Plaque
NCT02013349Not Applicable
DESolve Post-Approval Study
NCT04213599
The Angiography Characteristic of Free Wall Ruptrue in STEMI
NCT01760876Not Applicable
Evaluation of HealinG of Polymer-Free Biomlimus A9-Coated Stent by Optical Coherence Tomography (EGO-BIOFREEDOM)
NCT01031095Phase 3
(A Novel Pharmacologic Regime for Elective Percutaneous Coronary Intervention)
All 6 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 6